Angene Chemical
Draw
|
Currency :
Home Products

AG01DPZK

54276-21-0 | 5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (7Z)-

Chemical structure of 5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (7Z)-, CAS 54276-21-0
AG01DPZK
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 54276-21-0
Catalog Number AG01DPZK(AGN-PC-0SGWBY)
Chemical Name 5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (7Z)-
EC Number 255-028-8
IUPAC Name (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid
InChI InChI=1S/C22H29ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1
InChI Key VJGGHXVGBSZVMZ-QIZQQNKQSA-N
MDL Number MFCD00217060
Molecular Formula C22H29ClO6
Molecular Weight 424.9151
SMILES O[C@@H]1[C@H](C/C=CCCCC(O)=O)[C@@H](/C=C/[C@@H](O)COC2=CC=CC(Cl)=C2)[C@H](O)C1
UNII 52EJR3Y9IN
Synonyms
Cloprostenol, Cloprostenol Monosodium Salt, Cloprostenol Sodium, Estrumate, ICI 80,966, ICI-80,966, ICI80,966, Monosodium Salt, Cloprostenol, Oestrophan, Salt, Cloprostenol Monosodium, Sodium, Cloprostenol, cloprostenol, (+)-Cloprostenol, 54276-21-0, Estrofan, UNII-52EJR3Y9IN, 40665-92-7, Oestrophan, Estrumate, 52EJR3Y9IN, Estrophane, Oestrophane, Estrophan, CHEMBL37853, ICI 80996, Racemic cloprostenol, (+-)-Cloprostenol, Cloprostenol [INN:BAN], Cloprostenolum [INN-Latin], Cloprostenolum, Dalmazin, D-Cloprostenol, R-Cloprostenol, EINECS 255-028-8, Dalmaprost D, (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid, Cloprostenol, (+)-, C22H29ClO6, Estrumat, Planate, Ciosin, 206555-98-8, AC1NSJWQ, BSPBio_001579, SCHEMBL123595, GTPL1894, DTXSID7048372, HMS1791O21, HMS1989O21, HMS3402O21, HMS3648H06, (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid, 16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-rel-, 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1-alpha-(Z),2-beta-(1E,3R*),3-alpha,5-alpha)- (+-)-, ZINC4536236, BDBM50085910, AKOS015964975, AC-6104, CS-7779, IDI1_034049, NCGC00161343-01, NCGC00161343-02, NCGC00161343-03, (+-)-(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, (5Z)-, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-, AC-24773, AN-10393, HY-107381, X2624, 276C210, SR-01000946503, SR-01000946503-1, BRD-K17850764-001-02-6, BRD-K17850764-236-03-6, BRD-K17850764-236-08-5, UNII-4208238832 component VJGGHXVGBSZVMZ-QIZQQNKQSA-N, (5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid, (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl]hept-5-enoic acid, (Z)-7-{(1R,2R,3R,5S)-2-[(E)-(R)-4-(3-Chloro-phenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl}-hept-5-enoic acid, 5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (7Z)-, 7-{2-[4-(3-Chloro-phenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl}-hept-5-enoic acid, Cloprostenol sodium, Sodium, Cloprostenol, (+/-)-Cloprostenol, D0O9ES, Cloprostenol Monosodium Salt, Monosodium Salt, Cloprostenol, Salt, Cloprostenol Monosodium, C22-H29-Cl-O6, ICI80,966, UNII-4208238832, CID5311053, ICI 80,966, ICI-80,966, 2025A, D003008, ( -)-(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure, 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-)-, 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (5Z)-rel-, 5-Heptenoic acid, 7-[(1S,2S,3S,5R)-2-[(1E,3S)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (5Z)-, 5-Heptenoic acid, 7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+-.)-, 5-Heptenoic acid, 7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+.)-,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited